Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2006
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7019019 Matriptase inhibitors and methods of use
03/28/2006US7018797 Method for treating neurodegenerative disorders
03/28/2006CA2244862C Substituted amide derivatives
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006030208A1 Amino acid
03/23/2006WO2006029812A1 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006WO2005108355A3 Dihydrobenzothiophenes
03/23/2006US20060063943 Process for preparing optically active 3-(methylamino)-1-(2-thienyl) propan-1-ol and intermediates for preparation
03/23/2006US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
03/23/2006US20060063828 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
03/23/2006US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
03/23/2006US20060063769 Preventives/remedies for urinary disturbance
03/23/2006US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
03/23/2006US20060063760 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006DE10297824T5 Verfahren zum Einsatz von Wasserstoff zur reduktiven Acylierung von Nitro-, Azido- und Cyanarenen A method of using hydrogen for the reductive acylation of nitro, azido and cyano arenes
03/23/2006DE102004044827A1 Jod-phenylsubstituierte cyclische Ketoenole Iodine-substituted cyclic ketoenols
03/23/2006CA2580627A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006CA2580601A1 Novel compounds useful for modulating abnormal cell proliferation
03/23/2006CA2580131A1 Substituted aniline derivatives
03/23/2006CA2579799A1 Benzoyl-substituted serine amides
03/22/2006EP1637527A1 Cannabinoid receptor modulator
03/22/2006EP1636200A2 Inhibitors of papilloma virus
03/22/2006EP1636192A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
03/22/2006EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases
03/22/2006EP1554266B1 Process for preparing 2,5-disubstituted 3-alkylthiophenes
03/22/2006EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy
03/22/2006EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/22/2006CN1751036A Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof
03/22/2006CN1751022A Method for production of the R,R (or S,S) configuration of glycopyrronium stereoisomers
03/22/2006CN1749254A Double spiro material containing heteroaton and its synthetic method and use
03/22/2006CN1246319C Amino (thio) ether derivative
03/22/2006CN1246304C Intermediate product for preparing benzamidoxime derivative
03/21/2006US7015348 By means of catalytic and asymmetric synthesis method of high performance and high enantiomeric excess, which comprises subjecting an enamine to an asymmetric hydrogenation
03/21/2006US7015337 Process for preparing 5-aminomethyl-2-thiophenecarbonitrile HCl by one-pot reaction
03/21/2006US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
03/21/2006US7015243 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
03/21/2006US7014796 Irradiation with microwaves
03/21/2006CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
03/21/2006CA2181366C Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
03/21/2006CA2072416C Cyclopropenone derivatives
03/16/2006WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13
03/16/2006WO2006027684A1 Therapeutic diphenyl ether ligands
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058522 2-[(aminocarbonyl)amino]-5-(4-{[2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophene-3-carboxamide; I kappa B kinase-1(IKK-1) inhibitors; asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, bone resorptive disease, osteoarthritis
03/16/2006US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease
03/16/2006US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060057426 Thiophene derivative and organic electroluminescent element
03/16/2006US20060055088 Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping and method of optically forming tree-dimensional shape
03/16/2006CA2580024A1 Therapeutic diphenyl ether ligands
03/16/2006CA2579004A1 Mercaptoamides as histone deacetylase inhibitors
03/15/2006EP1635220A2 Oxime derivatives and the use thereof as photoinitiators
03/15/2006EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1633702A1 Protease inhibitors
03/15/2006EP1633701A1 Benzamide nitrile derivatives
03/15/2006EP1633699A2 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
03/15/2006EP1509530B1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1747948A Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents
03/15/2006CN1747947A A process for preparing duloxetine and intermediates for use therein
03/15/2006CN1245400C N-substituted benzothiophenesulfonamide derivatives
03/15/2006CN1245381C Phenylglycine derivatives
03/14/2006US7012153 Process for preparing benzoic acids
03/14/2006US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
03/14/2006US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
03/14/2006US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
03/14/2006CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors
03/09/2006WO2006024523A1 Phthalamide derivatives for use as insecticides
03/09/2006WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
03/09/2006US20060052608 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
03/09/2006US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
03/09/2006US20060049386 Microfiber articles from multi-layer substrates
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
03/08/2006EP1482924A4 Cathepsin cysteine protease inhibitors
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006EP0891330B1 Substituted phenyl keto enols as pesticides and herbicides
03/08/2006CN1745067A Biphenylcarboxamide compound
03/08/2006CN1743325A Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use
03/08/2006CN1244576C Chemical compounds
03/07/2006US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension
03/02/2006WO2006021213A2 Vasopressin v1a antagonists
03/02/2006WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
03/02/2006US20060047172 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight
03/02/2006US20060047123 Mercaptoamides as histone deacetylase inhibitors